Clinical Trial Update: Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy [Phase 4]

View source ↗

Summary

This trial update reports the withdrawal of a Phase 4 study evaluating Albis for prevention of upper gastrointestinal hemorrhage in patients with locally advanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Albis

Snippet

Sponsor: Yonsei University | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 4 | Status: WITHDRAWN